Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
McKinsey
Dow

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: pomalidomide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

pomalidomide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-501-00 100 CAPSULE in 1 BOTTLE (59572-501-00)
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-501-21 21 CAPSULE in 1 BOTTLE (59572-501-21)
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-502-00 100 CAPSULE in 1 BOTTLE (59572-502-00)
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-502-21 21 CAPSULE in 1 BOTTLE (59572-502-21)
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-503-00 100 CAPSULE in 1 BOTTLE (59572-503-00)
Celgene POMALYST pomalidomide CAPSULE;ORAL 204026 NDA Celgene Corporation 59572-503-21 21 CAPSULE in 1 BOTTLE (59572-503-21)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Express Scripts
Harvard Business School
McKesson
McKinsey